Your donation will make a difference:
Cystic Fibrosis Trust
Forum

Please Log in

Log in

Not a registered user? Register with us

This trial has been added to your watchlist.

Do you want to receive email notifications when the trial status changes?

No Yes

Unfollowing a trial will remove it from the watchlist and stop status change email notifications

Are you sure you want to unfollow this trial?

Yes, remove from watchlist

PlayPhysio Mobile App Study for young people with Cystic Fibrosis

Details

Therapeutic category
the type of treatment or therapy being studied. A therapy could range from a medication addressing a particular characteristic of CF to a device or activity e.g. exercise

Other

Trial status

Closed to recruitment

Participating Centres
Phase
the different stages involved in the development of a new medication. Phase I focuses on initial safety in people. Phase 2 evaluates safety, correct dose and early signs of whether the medication works. Phase 3 is the stage before medication licensing and looks at safety and medication effectiveness. Phase 4 evaluates longer term use of a medication after it has been licensed for use

Not Applicable

Full title

PlayPhysio Mobile App: Study of the safety and efficacy of the device in young people with Cystic Fibrosis and its impact on adherence to chest physiotherapy

There are many oscillatory PEP devices on the market to use for chest physiotherapy, with strong evidence that they are effective treatments in clearing the lungs. However, they don’t provide the user feedback to confirm that they are using the correct technique or indicate when each blow or treatment session has been completed. As a result this can lead parents to have a lack of confidence in whether their child is completing the physiotherapy session correctly or completely.A father of a CF patient has developed a device alongside the CF team at Cambridge University Hospital called Play Physio, that can be attached to any oscillatory PEP device. The patient can play games which have been designed to encourage the child to comply with the routine and data is collected and sent to the treating clinician in order to monitor compliance. The aims of this study are to look into the safety and efficacy of the Play Physio device and to investigate the effect of the device on compliance. This is a 24 week study in which the CF patients (ages 8-16) use the Play Physio ® device and associated app. Lung function, paper diaries, in app questionnaires and compliance data will all be analysed.

Trial Reference Number

110395

Trial type

Non-medication

Intervention
the name of the treatment or therapy being researched

Physiotherapy

Recruitment target
the number of participants who need to be recruited for the trial in the UK

30

Last edited date

27 February 2019

CF sponsor

Addenbrookes

CF sponsor type

Academic

Who can take part?

Top inclusion criteria
  • 8-16 year olds
  • Any child with Cystic Fibrosis between 8-16 who are under the care of Addenbrookes Hospital (as well as their shared care centres)
Top exclusion criteria
  • Sixteen year olds who are transitioning within the study period.
  • Children who would not be able to fill in questionnaires.
  • Children who have SPID (and therefore don’t do regular airway clearance).

CF centres running this trial

Closed

Addenbrooke's Hospital (CUH)

Address

Addenbrookes Hospital Hill Road Cambridge Cambridgeshire CB2 0QQ

Recruitment starts

October 2018

Contact

McShane, Donna

Get in touch